InvestorsHub Logo
icon url

williamssc

09/09/21 2:39 PM

#373815 RE: biopa #373812

Agree BP would want a good therapeutic even better a broad spectrum anti-viral. Last pr: "Brilacidin has shown potent and consistent inhibition in vitro against coronaviruses, alphaviruses and bunyaviruses (with laboratory testing against other viruses also underway), supporting Brilacidin’s potential to be developed as a broad-spectrum antiviral. The annual global antiviral drug market is estimated to reach $44 billion by 2026".